tolterodinetartraat accord 2 mg filmomhulde tabletten
accord healthcare b.v. winthontlaan 200 3526 kv utrecht - tolterodinetartraat 2 mg/stuk samenstelling overeenkomend met ; tolterodine 1,37 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; hypromellose (e 464) ; macrogol 8000 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; macrogol 8000 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; macrogol 8000 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - tolterodine
tolterodine 1mg film-coated tablets
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tolterodine l, tartrate - film-coated tablet - tolterodine l-tartrate 1 mg - urologicals
tolterodine 2mg film-coated tablets
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tolterodine l, tartrate - film-coated tablet - tolterodine l-tartrate 2 mg - urologicals
tolterodinetartraat viatris 1 mg filmomhulde tabletten
pfizer b.v. rivium westlaan 142 2909 ld capelle a/d ijssel - tolterodinetartraat 1 mg/stuk samenstelling overeenkomend met ; tolterodine 0,68 mg/stuk - filmomhulde tablet - calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460(i)) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), - tolterodine
tolterodinetartraat viatris 2 mg filmomhulde tabletten
pfizer b.v. rivium westlaan 142 2909 ld capelle a/d ijssel - tolterodinetartraat 2 mg/stuk samenstelling overeenkomend met ; tolterodine 1,37 mg/stuk - filmomhulde tablet - calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460(i)) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), - tolterodine
tolterodine tartrate tablet, film coated
macleods pharmaceuticals limited - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 1 mg - tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. tolterodine tartrate tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate is also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate, are metabolized to 5-hydroxymethyl tolterodine.
tolterodine tartrate- tolterodine tartrate tablet, film coated
remedyrepack inc. - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. tolterodine tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tablets are also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tablets, are metabolized to 5-hydroxymethyl tolterodine.
tolterodine tartrate tablet, film coated
greenstone llc - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 1 mg - tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. tolterodine tartrate tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate is also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate, are metabolized to 5-hydroxymethyl tolterodine.
tolterodine tartrate capsule, extended release
teva pharmaceuticals usa, inc. - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 2 mg - tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see clinical studies (14) ]. tolterodine tartrate extended-release capsules are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate extended-release capsules are also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate extended-release capsules, are metabolized to 5-hydroxymethyl tolterodine [see warnings and precautions (5.2), (5.3), (5.4) ]. risk summary there are no available data with tolterodine tartrate extended-release capsules use in pregnant women to inform drug-associated risks. in animal reproduction studies, oral administration of tolterodine and its 5-hmt metabolite to pregnant mice during organogenesis did not produce adverse develo
tolterodine tartrate capsule, extended release
golden state medical supply, inc. - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 2 mg - tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see clinical studies (14)] . tolterodine tartrate extended-release capsules are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate extended-release capsules are also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate extended-release capsules, are metabolized to 5-hydroxymethyl tolterodine [see warnings and precautions (5.2), ( 5.3), ( 5.4)] . there are no available data with tolterodine tartrate extended-release capsules use in pregnant women to inform drug-associated risks. in animal reproduction studies, oral administration of to